Il-kodiċi HS/NM 3005 huwa barra mill-kamp ta’ applikazzjoni għat-tħejjija għall-EUDR.
Wadding, gauze, bandages and the like, e.g. dressings, adhesive plasters, poultices, impregnated or covered with pharmaceutical substances or put up for retail sale for medical, surgical, dental or veterinary purposes Il-magna indiċizzata tal-kamp ta’ applikazzjoni tagħti Out of scope għal dan il-kodiċi. No Annex I scope match was found for this indexed CN code.
Għaliex din il-paġna ta’ referenza tagħti dik it-tweġiba.
- Deskrizzjoni tal-kodiċi
- Wadding, gauze, bandages and the like, e.g. dressings, adhesive plasters, poultices, impregnated or covered with pharmaceutical substances or put up for retail sale for medical, surgical, dental or veterinary purposes
- Bażi fl-Anness I
- L-ebda entrata diretta fl-Anness I
- Bażi tas-sors
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Ringieli ġenituri, subordinati u viċini.
Il-veduta tal-librerija hija għan-navigazzjoni ta’ referenza. Uża l-verifikatur meta trid tiċċekkja kodiċi ieħor bħala azzjoni.
30prodotti farmaċewtiċiout300510adhesive dressings and other articles having an adhesive layer, impregnated or covered with pharmaceutical substances or put up for retail sale for medical, surgical, dental or veterinary purposesout300590wadding, gauze, bandages and the like, e.g. dressings, adhesive plasters, poultices, impregnated or covered with pharmaceutical substances or put up for retail sale for medical, surgical, dental or veterinary purposes (excl. adhesive dressings and other articles having an adhesive layer)out3001dried glands and other organs for organo-therapeutic uses, whether or not powdered; extracts of glands or other organs or their secretions, for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, n.e.s.out3002human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar productsout3003medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006)out3004medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. goods of heading 3002, 3005 or 3006)out3006pharmaceutical preparations and products of subheadings 3006.10.10 to 3006.60.90out
Xi jfisser dan għat-tħejjija.
Din ir-ringiela mhijiex skattatur dirett għall-ġbir tal-evidenza fir-riżultat attwali tal-kamp ta’ applikazzjoni.
Regulation (EU) 2023/1115 Annex I — relevant productsmiksub fi 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115miksub fi 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)miksub fi 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)miksub fi 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8miksub fi 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingmiksub fi 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersmiksub fi 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)miksub fi 2026-08-08